To evaluate the effect of HDACs ablation on tumor growth in vivo, we grafted the stable HDAC1/2-deficient and control Med1-MB cells into flanks of athymic nude CD1 mice and monitored the growth of the tumor volume over time. Here, HDAC1 is linked to neoplasm.